Cargando…
Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon
The human type I interferon (IFN) system is central to innate immune defense, and is essential to protect individuals against severe viral disease. Consequently, genetic disruption of IFN signaling or effector mechanisms is extremely rare, as affected individuals typically suffer life-threatening in...
Autores principales: | Mair, Nina K., Hale, Benjamin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468519/ https://www.ncbi.nlm.nih.gov/pubmed/36100643 http://dx.doi.org/10.1038/s41598-022-19648-w |
Ejemplares similares
-
BRD9 is a druggable component of interferon‐stimulated gene expression and antiviral activity
por: Börold, Jacob, et al.
Publicado: (2021) -
BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
por: Ahmed, Nasiha S., et al.
Publicado: (2021) -
FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling
por: Zhou, Dawei, et al.
Publicado: (2021) -
Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021) -
Histone H2A.Z Suppression of Interferon-Stimulated Transcription and Antiviral Immunity Is Modulated by GCN5 and BRD2
por: Au-Yeung, Nancy, et al.
Publicado: (2018)